{"id":2781,"date":[82],"date_gmt":"2024-03-26T17:16:19","guid":{"rendered":"https:\/\/hcp.biomarin.com\/en-gb\/achondroplasia\/?post_type=resource&p=2781"},"modified":"2024-05-14T09:45:16","modified_gmt":"2024-05-14T09:45:16","slug":"real-world-safety-and-effectiveness-of-vosoritide%e2%96%bc-results-from-an-early-access-program-in-france","status":"publish","type":"resource","link":"https:\/\/hcp.biomarin.com\/en-gb\/achondroplasia\/expert\/resource\/real-world-safety-and-effectiveness-of-vosoritide%e2%96%bc-results-from-an-early-access-program-in-france\/","title":{"rendered":"Results from an Early Access Program in France"},"content":{"rendered":"","protected":false},"author":4,"template":"","format":[30],"topic":[46],"key_opinion_leader":[],"audience":[],"disease_state":[],"region":[39],"product":[59],"acf":[],"yoast_head":"\n